DiagnoSwiss is currently commercialising its products named ImmuSpeed/ImmuChips and GRAVI-Cell/GRAVI-Chips. These microfluidic platforms are ELISA analysers designed to meet the increasing needs of the life sciences for fast and high-performance analyses in low volumes. DiagnoSwiss’ chips speed up bioanalytics and reduce laboratory costs, and they have also been used as mass spectrometry injection tips.
These chips have first been dedicated to protein analysis in human IVD, but they also find many applications in pharmaceutical research, industrial control, food safety or bioterrorism.
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.
